ID CRK_CHICK Reviewed; 305 AA. AC Q04929; DT 01-NOV-1995, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1995, sequence version 1. DT 24-JAN-2024, entry version 148. DE RecName: Full=Adapter molecule crk; DE AltName: Full=Proto-oncogene c-Crk; DE AltName: Full=p38; GN Name=CRK; OS Gallus gallus (Chicken). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; OC Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae; OC Phasianinae; Gallus. OX NCBI_TaxID=9031; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=1329926; RA Reichman C.T., Mayer B.J., Khawer S., Hanafusa H.; RT "The product of the cellular crk gene consists primarily of SH2 and SH3 RT regions."; RL Cell Growth Differ. 3:451-460(1992). RN [2] RP STRUCTURE BY NMR OF 135-297, AND ISOMERIZATION AT PRO-238. RX PubMed=21131971; DOI=10.1038/nchembio.494; RA Sarkar P., Saleh T., Tzeng S.R., Birge R.B., Kalodimos C.G.; RT "Structural basis for regulation of the Crk signaling protein by a proline RT switch."; RL Nat. Chem. Biol. 7:51-57(2011). CC -!- FUNCTION: May mediate attachment-induced MAPK8 activation, membrane CC ruffling and cell motility in a Rac-dependent manner. Involved in CC phagocytosis of apoptotic cells and cell motility (By similarity). CC Involved in cell branching and adhesion (By similarity). May regulate CC the EFNA5-EPHA3 signaling (By similarity). {ECO:0000250, CC ECO:0000250|UniProtKB:P46108, ECO:0000250|UniProtKB:Q64010}. CC -!- SUBUNIT: Interacts with ABL1, C3G, SOS, MAP4K1, MAPK8 and DOCK1 via its CC first SH3 domain. Interacts with BCAR1, CBL, PXN and GAB1 via its SH2 CC domain upon stimulus-induced tyrosine phosphorylation. Interacts with CC several tyrosine-phosphorylated growth factor receptors such as EGFR, CC PDGFR and INSR via its SH2 domain (By similarity). {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane CC {ECO:0000250}. Note=Translocated to the plasma membrane upon cell CC adhesion. {ECO:0000250}. CC -!- PTM: Phosphorylated on Tyr-222 upon cell adhesion. Results in the CC negative regulation of the association with SH2- and SH3-binding CC partners, possibly by the formation of an intramolecular interaction of CC phosphorylated Tyr-222 with the SH2 domain. This leads finally to the CC down-regulation of the Crk signaling pathway (By similarity). CC {ECO:0000250}. CC -!- PTM: Proline isomerization at Pro-238 by PPIA acts as a switch between CC two conformations: an autoinhibitory conformation in the cis form, CC where the tandem SH3 domains interact intramolecularly, and an CC activated conformation in the trans form. CC {ECO:0000269|PubMed:21131971}. CC -!- SIMILARITY: Belongs to the CRK family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; L08168; AAA49001.1; -; mRNA. DR PIR; A49011; A49011. DR RefSeq; NP_001007847.1; NM_001007846.1. DR RefSeq; XP_015151517.1; XM_015296031.1. DR PDB; 2L3P; NMR; -; A=220-297. DR PDB; 2L3Q; NMR; -; A=220-297. DR PDB; 2L3S; NMR; -; A=135-297. DR PDBsum; 2L3P; -. DR PDBsum; 2L3Q; -. DR PDBsum; 2L3S; -. DR AlphaFoldDB; Q04929; -. DR BMRB; Q04929; -. DR SMR; Q04929; -. DR BioGRID; 678886; 2. DR IntAct; Q04929; 3. DR MINT; Q04929; -. DR STRING; 9031.ENSGALP00000004174; -. DR iPTMnet; Q04929; -. DR PaxDb; 9031-ENSGALP00000004174; -. DR Ensembl; ENSGALT00000004183; ENSGALP00000004174; ENSGALG00000002656. DR Ensembl; ENSGALT00010070926.1; ENSGALP00010043617.1; ENSGALG00010029327.1. DR Ensembl; ENSGALT00015055399; ENSGALP00015033483; ENSGALG00015022653. DR VEuPathDB; HostDB:geneid_107054794; -. DR eggNOG; KOG4792; Eukaryota. DR GeneTree; ENSGT00820000127055; -. DR HOGENOM; CLU_060542_0_1_1; -. DR InParanoid; Q04929; -. DR OMA; DNHMIIE; -. DR OrthoDB; 2900795at2759; -. DR PhylomeDB; Q04929; -. DR TreeFam; TF321436; -. DR Reactome; R-GGA-170984; ARMS-mediated activation. DR Reactome; R-GGA-186763; Downstream signal transduction. DR Reactome; R-GGA-2029482; Regulation of actin dynamics for phagocytic cup formation. DR Reactome; R-GGA-372708; p130Cas linkage to MAPK signaling for integrins. DR Reactome; R-GGA-4420097; VEGFA-VEGFR2 Pathway. DR Reactome; R-GGA-8849471; PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases. DR Reactome; R-GGA-8875555; MET activates RAP1 and RAC1. DR Reactome; R-GGA-8875656; MET receptor recycling. DR Reactome; R-GGA-912631; Regulation of signaling by CBL. DR EvolutionaryTrace; Q04929; -. DR PRO; PR:Q04929; -. DR Proteomes; UP000000539; Chromosome 19. DR Bgee; ENSGALG00000002656; Expressed in lung and 13 other cell types or tissues. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0016020; C:membrane; ISS:UniProtKB. DR GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell. DR GO; GO:0032991; C:protein-containing complex; IEA:Ensembl. DR GO; GO:0046875; F:ephrin receptor binding; IEA:Ensembl. DR GO; GO:0001784; F:phosphotyrosine residue binding; IEA:Ensembl. DR GO; GO:0043621; F:protein self-association; IEA:Ensembl. DR GO; GO:0030971; F:receptor tyrosine kinase binding; IBA:GO_Central. DR GO; GO:0042169; F:SH2 domain binding; IEA:Ensembl. DR GO; GO:0017124; F:SH3 domain binding; IEA:Ensembl. DR GO; GO:0035591; F:signaling adaptor activity; IBA:GO_Central. DR GO; GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl. DR GO; GO:0016477; P:cell migration; IBA:GO_Central. DR GO; GO:0048013; P:ephrin receptor signaling pathway; ISS:UniProtKB. DR GO; GO:2000146; P:negative regulation of cell motility; IEA:Ensembl. DR GO; GO:0061045; P:negative regulation of wound healing; IEA:Ensembl. DR GO; GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IEA:Ensembl. DR GO; GO:0032956; P:regulation of actin cytoskeleton organization; ISS:UniProtKB. DR GO; GO:0008360; P:regulation of cell shape; IEA:Ensembl. DR GO; GO:0043087; P:regulation of GTPase activity; ISS:UniProtKB. DR GO; GO:1902531; P:regulation of intracellular signal transduction; IEA:Ensembl. DR GO; GO:0007165; P:signal transduction; IBA:GO_Central. DR CDD; cd09926; SH2_CRK_like; 1. DR CDD; cd11759; SH3_CRK_C; 1. DR CDD; cd11758; SH3_CRK_N; 1. DR Gene3D; 3.30.505.10; SH2 domain; 1. DR Gene3D; 2.30.30.40; SH3 Domains; 2. DR InterPro; IPR035458; CRK_SH3_C. DR InterPro; IPR035457; CRK_SH3_N. DR InterPro; IPR000980; SH2. DR InterPro; IPR036860; SH2_dom_sf. DR InterPro; IPR036028; SH3-like_dom_sf. DR InterPro; IPR001452; SH3_domain. DR PANTHER; PTHR19969:SF8; ADAPTER MOLECULE CRK; 1. DR PANTHER; PTHR19969; SH2-SH3 ADAPTOR PROTEIN-RELATED; 1. DR Pfam; PF00017; SH2; 1. DR Pfam; PF00018; SH3_1; 1. DR Pfam; PF07653; SH3_2; 1. DR PRINTS; PR00401; SH2DOMAIN. DR PRINTS; PR00452; SH3DOMAIN. DR SMART; SM00252; SH2; 1. DR SMART; SM00326; SH3; 2. DR SUPFAM; SSF55550; SH2 domain; 1. DR SUPFAM; SSF50044; SH3-domain; 2. DR PROSITE; PS50001; SH2; 1. DR PROSITE; PS50002; SH3; 2. PE 1: Evidence at protein level; KW 3D-structure; Cell membrane; Cytoplasm; Membrane; Phosphoprotein; KW Proto-oncogene; Reference proteome; Repeat; SH2 domain; SH3 domain. FT CHAIN 1..305 FT /note="Adapter molecule crk" FT /id="PRO_0000079349" FT DOMAIN 13..119 FT /note="SH2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00191" FT DOMAIN 133..193 FT /note="SH3 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00192" FT DOMAIN 236..297 FT /note="SH3 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00192" FT REGION 194..231 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 194..212 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT SITE 238 FT /note="Proline switch" FT /evidence="ECO:0000269|PubMed:21131971" FT MOD_RES 222 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250" FT STRAND 137..140 FT /evidence="ECO:0007829|PDB:2L3S" FT STRAND 148..151 FT /evidence="ECO:0007829|PDB:2L3S" FT STRAND 156..164 FT /evidence="ECO:0007829|PDB:2L3S" FT STRAND 166..174 FT /evidence="ECO:0007829|PDB:2L3S" FT STRAND 176..178 FT /evidence="ECO:0007829|PDB:2L3S" FT STRAND 180..184 FT /evidence="ECO:0007829|PDB:2L3S" FT HELIX 185..187 FT /evidence="ECO:0007829|PDB:2L3S" FT STRAND 200..203 FT /evidence="ECO:0007829|PDB:2L3S" FT STRAND 226..228 FT /evidence="ECO:0007829|PDB:2L3P" FT STRAND 234..236 FT /evidence="ECO:0007829|PDB:2L3P" FT STRAND 239..245 FT /evidence="ECO:0007829|PDB:2L3P" FT STRAND 253..255 FT /evidence="ECO:0007829|PDB:2L3P" FT STRAND 263..269 FT /evidence="ECO:0007829|PDB:2L3P" FT STRAND 272..274 FT /evidence="ECO:0007829|PDB:2L3P" FT STRAND 277..280 FT /evidence="ECO:0007829|PDB:2L3P" FT STRAND 283..286 FT /evidence="ECO:0007829|PDB:2L3P" FT HELIX 289..291 FT /evidence="ECO:0007829|PDB:2L3Q" FT STRAND 292..295 FT /evidence="ECO:0007829|PDB:2L3Q" SQ SEQUENCE 305 AA; 33806 MW; 0A79AD232E824768 CRC64; MAGQFDSEDR GSWYWGRLSR GDAVSLLQGQ RHGTFLVRDS GSIPGDFVLS VSESSRVSHY IVNSLGPAGG RRAGGEGPGA PGLNPTRFRI GDQEFDSLPS LLEFYKIHYL DTTTLIEPVS RSRQNSGVIL RQEEVEYVRA LFDFNGNDDE DLPFKKGDIL KIRDKPEEQW WNAEDMDGKR GMIPVPYVEK CRPSSASVST LTGGNQDSSH PQPLGGPEPG PYAQPSINTP LPNLQNGPFY ARVIQKRVPN AYDKTALALE VGELVKVTKI NMSGQWEGEC NGKRGHFPFT HVRLLDQQNP DEDFS //